Blocking Wnt/β‐catenin signaling by XAV939 antagonist leads to significant inhibition of the ALDH‐positive populations and re‐sensitization of the PCa cells to radiation therapy.283. This evidence concerns the gene LDHA and posterior cortical atrophy.